Genetic engineering of mesenchymal stem cells and its application in human disease therapy
- PMID: 20825283
- PMCID: PMC2978545
- DOI: 10.1089/hum.2010.165
Genetic engineering of mesenchymal stem cells and its application in human disease therapy
Abstract
The use of stem cells for tissue regeneration and repair is advancing both at the bench and bedside. Stem cells isolated from bone marrow are currently being tested for their therapeutic potential in a variety of clinical conditions including cardiovascular injury, kidney failure, cancer, and neurological and bone disorders. Despite the advantages, stem cell therapy is still limited by low survival, engraftment, and homing to damage area as well as inefficiencies in differentiating into fully functional tissues. Genetic engineering of mesenchymal stem cells is being explored as a means to circumvent some of these problems. This review presents the current understanding of the use of genetically engineered mesenchymal stem cells in human disease therapy with emphasis on genetic modifications aimed to improve survival, homing, angiogenesis, and heart function after myocardial infarction. Advancements in other disease areas are also discussed.
Figures
Similar articles
-
From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.J Cell Physiol. 2007 Apr;211(1):27-35. doi: 10.1002/jcp.20959. J Cell Physiol. 2007. PMID: 17226788 Review.
-
The therapeutic potential of mesenchymal stem cells for cardiovascular diseases.Cell Death Dis. 2020 May 11;11(5):349. doi: 10.1038/s41419-020-2542-9. Cell Death Dis. 2020. PMID: 32393744 Free PMC article. Review.
-
Concise review: mesenchymal stromal cells: potential for cardiovascular repair.Stem Cells. 2008 Sep;26(9):2201-10. doi: 10.1634/stemcells.2008-0428. Epub 2008 Jul 3. Stem Cells. 2008. PMID: 18599808 Review.
-
Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine.J Cell Mol Med. 2009 Nov-Dec;13(11-12):4385-402. doi: 10.1111/j.1582-4934.2009.00857.x. Epub 2009 Jul 10. J Cell Mol Med. 2009. PMID: 19602034 Free PMC article. Review.
-
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.Adv Drug Deliv Rev. 2010 Sep 30;62(12):1167-74. doi: 10.1016/j.addr.2010.09.013. Epub 2010 Oct 13. Adv Drug Deliv Rev. 2010. PMID: 20920540 Free PMC article. Review.
Cited by
-
Recent advances in the therapeutic efficacy of hepatocyte growth factor gene-modified mesenchymal stem cells in multiple disease settings.J Cell Mol Med. 2022 Sep;26(18):4745-4755. doi: 10.1111/jcmm.17497. Epub 2022 Aug 3. J Cell Mol Med. 2022. PMID: 35922965 Free PMC article. Review.
-
Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.Cancer Gene Ther. 2015 Jan;22(1):44-54. doi: 10.1038/cgt.2014.68. Epub 2014 Dec 19. Cancer Gene Ther. 2015. PMID: 25525034
-
Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology.Circ Res. 2016 Jan 8;118(1):95-107. doi: 10.1161/CIRCRESAHA.115.305373. Circ Res. 2016. PMID: 26837742 Free PMC article. Review.
-
Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation.Stem Cell Res Ther. 2021 May 29;12(1):314. doi: 10.1186/s13287-021-02402-w. Stem Cell Res Ther. 2021. PMID: 34051857 Free PMC article.
-
The Roles of Nanoparticles in Stem Cell-Based Therapy for Cardiovascular Disease.Front Bioeng Biotechnol. 2020 Aug 14;8:947. doi: 10.3389/fbioe.2020.00947. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32923434 Free PMC article. Review.
References
-
- Abdallah B.M. Haack-Sorensen M. Burns J.S. Elsnab B. Jakob F. Hokland P. Kassem M. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem. Biophys. Res. Commun. 2005;326:527–538. - PubMed
-
- Aguayo-Mazzucato C. Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2010;6:139–148. - PubMed
-
- Arguero R. Careaga-Reyna G. Castano-Guerra R. Garrido-Garduno M.H. Magana-Serrano J.A. de Jesus Nambo-Lucio M. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy: Preliminary report. Arch. Med. Res. 2006;37:1010–1014. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources